121 related articles for article (PubMed ID: 18575719)
1. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma.
Antonaci A; Consorti F; Mardente S; Natalizi S; Giovannone G; Della Rocca C
Oncol Rep; 2008 Jul; 20(1):63-7. PubMed ID: 18575719
[TBL] [Abstract][Full Text] [Related]
2. Microcarcinoma and incidental carcinoma of the thyroid in a clinical series: clinical behaviour and surgical management.
Antonaci A; Anello A; Aucello A; Consorti F; Della Rocca C; Giovannone G; Scardella L
Clin Ter; 2006; 157(3):225-9. PubMed ID: 16900848
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
4. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Temmim L; Ebraheem AK; Baker H; Sinowatz F
Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 expression in primary thyroid carcinomas.
Sporny S; Slowinska-Klencka D; Ratynska M
Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
[TBL] [Abstract][Full Text] [Related]
8. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.
Timler D; Tazbir J; Matejkowska M; Gosek A; Czyz W; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():201-2. PubMed ID: 11820608
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
11. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
12. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
13. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697
[TBL] [Abstract][Full Text] [Related]
14. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.
Ito Y; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Oncology; 2005; 68(2-3):87-96. PubMed ID: 15886500
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
16. [Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma].
Wang Y; Ji QH; Huang CP; Zhu YX; Zhang L
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(24):1899-901. PubMed ID: 19134382
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
18. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.
Lamba Saini M; Bouzin C; Weynand B; Marbaix E
PLoS One; 2016; 11(2):e0148656. PubMed ID: 26863116
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
Barić A; Marković V; Eterović D; Bedeković V; Kontić M; Juretić Kuščić L; Pešutić Pisac V; Punda A
Acta Clin Croat; 2017 Mar; 56(1):15-20. PubMed ID: 29120119
[TBL] [Abstract][Full Text] [Related]
20. Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters.
Bal N; Kocer NE; Ertorer ME; Canpolat ET; Kayaselcuk F
Pathol Res Pract; 2008; 204(10):743-50. PubMed ID: 18597952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
